reference/28344992

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28344992

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	1145
issn	0022-3050 1468-330X
issueIdentifier	10
pageRange	1138-1145
publicationName	Journal of neurology, neurosurgery, and psychiatry
startingPage	1138
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f4c334781d38c999cf043344a301e8fb
bibliographicCitation	Wijburg MT, Witte BI, Vennegoor A, Roosendaal SD, Sanchez E, Liu Y, Martins Jarnalo CO, Uitdehaag BM, Barkhof F, Killestein J, Wattjes MP. MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance. J Neurol Neurosurg Psychiatry. 2016 Oct;87(10):1138–45. doi: 10.1136/jnnp-2016-313772. PMID: 27530808.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6347-5957 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8292e72f87b2af3e838d820ff9c6f2c5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97899f8018f52ae0449888119a7e2d8f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a94490fbb8c6dd8fd4fdd68d2e7fb9b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c623d4f52edc7b133cc8f0ad00f2668 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f054e1febdf3593a428a381fd7e12d0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_87b81db4bf229701230466f936310f82 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13df0e0d95873c5dc769590bf1f9960c http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3543-3706 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_675652f30bdd2357e1e8de2e836c2e1f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1dca320fffe440579e2b5743e409d79d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_087776bafcf8e2b67a9740d56d2e897e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e747b3058dce216458d81372c4c7a6fd
date	2016-08-16^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/27530808 https://doi.org/10.1136/jnnp-2016-313772
isPartOf	https://portal.issn.org/resource/ISSN/1468-330X https://portal.issn.org/resource/ISSN/0022-3050 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5009
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance
discusses	http://id.nlm.nih.gov/mesh/M0443607 http://id.nlm.nih.gov/mesh/M0011157
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008279 http://id.nlm.nih.gov/mesh/D007968Q000139 http://id.nlm.nih.gov/mesh/D060735 http://id.nlm.nih.gov/mesh/D007968Q000000981 http://id.nlm.nih.gov/mesh/D000069442Q000627 http://id.nlm.nih.gov/mesh/D000069442Q000009 http://id.nlm.nih.gov/mesh/D007155Q000009 http://id.nlm.nih.gov/mesh/D020529Q000188 http://id.nlm.nih.gov/mesh/D007155Q000627 http://id.nlm.nih.gov/mesh/D020529Q000000981
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D003937 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8319 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b3e16b7e6839442a63a7c39be7e1b1ec http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8532

Showing number of triples: 1 to 56 of 56.